RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 FFR-Guided PCI Offers Cost-Effective Benefit Compared with Medical Therapy Alone
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 17
SP 20
OP 21
DO 10.1177/155989771217008
UL http://mdc.sagepub.com/content/12/17/20.abstract
AB A cost-effectiveness analysis of the Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Therapy (OMT) Versus OMT [FAME 2] trial indicates that FFR-guided PCI is economically viable. The initial cost of FFR-guided PCI is higher than that of medical therapy, but the cost gap narrows by >50% at 1 year.